Evidence map›Paper›PMID 35874750›Full record

ArticleFrontiers in immunology2022

Analysis of the Genomic Sequence of

Yanmin He, Xiaozhen Hong, Jingjing Zhang, Ji He, Faming Zhu, He Huang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. [Rh blood group: Review and importance of genotyping].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Review
  4. Utility ofAnnals of laboratory medicine · 2025
    Article
  5. Characterization of a novelFrontiers in immunology · 2024
    Article
  6. Investigation ofAnimals : an open access journal from MDPI · 2023
    Article
  7. A case of trisomy 9 with mixed-field ABO blood type.Blood transfusion = Trasfusione del sangue
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yanmin HeBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Xiaozhen HongInstitute of Transfusion medicine, Blood Center of Zhejiang Province, Hangzhou, China.
Jingjing ZhangInstitute of Transfusion medicine, Blood Center of Zhejiang Province, Hangzhou, China.
Ji HeInstitute of Transfusion medicine, Blood Center of Zhejiang Province, Hangzhou, China.
Faming ZhuInstitute of Transfusion medicine, Blood Center of Zhejiang Province, Hangzhou, China.
He HuangBone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Blood Center of Zhejiang Province · CNFirst Affiliated Hospital Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Although many molecular diagnostic methods have been used for Study Design and Methods: Two pairs of primers covering the partial 5'-untranslated region (UTR) to 3'-UTR of the Results: Among the 88 blood donors with a normal phenotype, 48 homozygous individuals, 39 heterozygous individuals, and one individual with a novel Conclusion: An NGS method was established to analyze the sequence from the start codon to the stop codon of the

Indexed as

GenomicsHigh-Throughput Nucleotide SequencingAllelesCodon, InitiatorCodon, TerminatorDNAGenotypeCodon, InitiatorCodon, TerminatorDNAABO subtypesallele recombinationan erythroid cell-specific regulatory elementnext-generation sequencingsingle nucleotide variant

Identifiers

PMID35874750
PMCPMC9298404
OpenAlexW4283823114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.